ZED1227 is a transglutaminase 2 (TG2) inhibitor developed by Zedira GmbH for celiac disease and nonalcoholic steatohepatitis.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.